Cardiac

  • Medtronic's Jason Fontana is wearing a blue suit and blue patterned tie in a headshot.
    Image attribution tooltip
    Courtesy of Medtronic
    Image attribution tooltip
    Q&A

    Medtronic’s Jason Fontana on ramping up renal denervation

    The general manager for the business says building a market is something the medtech giant knows how to do.

    By • Nov. 5, 2025
  • A corporate building for Edwards Lifesciences.
    Image attribution tooltip
    Courtesy of Edwards Lifesciences
    Image attribution tooltip

    Edwards CFO Scott Ullem to exit post

    Ullem, who has held the position for more than a decade, will transition to an advisory role after his replacement is named by mid-2026.

    By • Oct. 31, 2025
  • Boston Scientific's Farapulse pulsed field ablation device. Explore the Trendline➔
    Image attribution tooltip
    Permission granted by Boston Scientific
    Image attribution tooltip
    Trendline

    New medical devices are reshaping the medtech industry

    From pulsed field ablation devices to glucose sensors and surgical robotics, new medical technologies are transforming patient care and how people manage their health.

    By MedTech Dive staff
  • Two clinicians view data showing the condition of a patient's arteries on a large screen.
    Image attribution tooltip
    Courtesy of Philips
    Image attribution tooltip

    3 takeaways from TCT 2025

    Trials from Edwards, Philips and Penumbra were among the most-watched studies at the annual cardiovascular meeting.

    By • Oct. 31, 2025
  • Rendering of a spiral-shaped catheter with four electrodes
    Image attribution tooltip
    Permission granted by Medtronic
    Image attribution tooltip

    CMS grants NCD for renal denervation, benefiting Medtronic, Recor

    National Medicare coverage paves the way for a larger patient population to access the blood pressure treatment, which gained FDA approval in 2023.

    By • Oct. 29, 2025
  • A coil-shaped device is shown moving through a tube with branching structures around it.
    Image attribution tooltip
    Courtesy of Medtronic
    Image attribution tooltip

    Medtronic links renal denervation to 3-year blood pressure reduction

    Patients treated with Symplicity Spyral had significantly lower blood pressure than people who received a sham treatment after three years.

    By • Oct. 28, 2025
  • The robot-enhanced heart valve replacement system is depicted in an illustration that includes a patient on a table.
    Image attribution tooltip
    Courtesy of CardioPrecision
    Image attribution tooltip
    Profile

    Corcym, CardioPrecision set sights on robotic heart valve replacement

    The companies have teamed to develop an alternative to TAVR that combines the benefits of a less-invasive procedure with the longer-term advantages of open heart surgery.

    By • Oct. 27, 2025
  • Aerial view of a sprawling Boston Scientific manufacturing plant
    Image attribution tooltip
    Courtesy of Boston Scientific
    Image attribution tooltip

    Boston Scientific continues to win in electrophysiology

    Strong sales growth in the company’s electrophysiology unit comes amid a market fight between some of the medtech industry’s largest players.

    By • Oct. 22, 2025
  • Person wears Oura ring in a car
    Image attribution tooltip
    Courtesy of Oura
    Image attribution tooltip

    Ōura to pursue FDA clearance of blood pressure feature for smart ring

    The company has received approval to validate and define the feature in a study that is scheduled to start this year.

    By • Oct. 20, 2025
  • Modern glass and metal office building with a reflective blue-tinted facade, set against a clear blue sky. In the foreground, a large black and white sign reads “Abbott” with the company’s stylized logo and the number “645.” The area has neatly cut grass and a few small trees.
    Image attribution tooltip
    Alamy
    Image attribution tooltip

    Abbott CEO: ‘We’re right on time’ to the PFA party

    As competitors have launched their first pulsed field ablation devices in the U.S., Abbott CEO Robert Ford told investors that the company is not just playing defense.

    By • Oct. 15, 2025
  • An anatomical heart is pictured in red in a transparent body.
    Image attribution tooltip
    Getty Images
    Image attribution tooltip

    Stereotaxis teams with CardioFocus to develop robotic PFA system

    Stereotaxis CEO David Fischel said the precision, stability and safety profile of robotics are a good fit for pulsed field ablation.

    By • Oct. 15, 2025
  • illustration of a heart showing a tube-shaped device going into the left ventricle
    Image attribution tooltip
    Courtesy of Abiomed
    Image attribution tooltip

    Cybersecurity triggers another recall of J&J’s Impella heart pump controller

    While no patients have been harmed, the FDA categorized the action as a Class I recall because of the potential for serious injury or death.

    By • Oct. 14, 2025
  • The exterior of Medtronic's Minnesota operational headquarters is shown along with its reflection in a pool of water.
    Image attribution tooltip
    Courtesy of Medtronic
    Image attribution tooltip

    Medtronic wins CE mark for Penditure LAA exclusion device

    The company plans to launch the device in Europe late next week, providing competition for AtriCure’s AtriClip product.

    By • Oct. 3, 2025
  • Boston Scientific's Farapulse pulsed field ablation device.
    Image attribution tooltip
    Permission granted by Boston Scientific
    Image attribution tooltip

    Boston Scientific aims for market leadership in electrophysiology

    The company has now treated 500,000 patients with its pulsed field ablation system, in a competitive category poised for growth.

    By • Oct. 2, 2025
  • A rendering of a rounded device with a wire structure surrounded by mesh.
    Image attribution tooltip
    Courtesy of Boston Scientific
    Image attribution tooltip

    Boston Scientific unveils plans for new Watchman device

    The company hopes to launch its next-generation Watchman system in the second half of 2027 or early 2028.

    By • Updated Oct. 14, 2025
  • Heartflow
    Image attribution tooltip
    Courtesy of HeartFlow
    Image attribution tooltip

    Heartflow receives FDA clearance for updated plaque analysis platform

    The updated algorithm shows a 21% improvement in plaque detection, compared to the original version.

    By • Sept. 25, 2025
  • An anatomical heart is pictured in red in a transparent body.
    Image attribution tooltip
    Getty Images
    Image attribution tooltip

    Cardiosense names Eric Meizlish as CEO

    Cardiosense’s switch to a leader with experience scaling healthtech companies comes as it works to build on the recent 510(k) clearance of CardioTag.

    By • Updated Sept. 25, 2025
  • illustration of a heart showing a tube-shaped device going into the left ventricle
    Image attribution tooltip
    Courtesy of Abiomed
    Image attribution tooltip

    J&J’s Abiomed starts third heart pump controller recall since June

    As of Aug. 27, the company had reported five serious injuries and no deaths associated with the issue.

    By • Sept. 24, 2025
  • SS Innovations CEO Sudhir Srivastava is seated at the surgeon's console of the company's SSi Mantra robotic surgery system.
    Image attribution tooltip
    Permission granted by SS Innovations
    Image attribution tooltip
    Profile

    How SS Innovations is expanding robotic surgery’s reach

    Heart surgeon Sudhir Srivastava saw a global need for less-invasive surgical care at an affordable price. His company, SS Innovations, built a robot that has now been used in more than 5,000 surgeries.

    By • Sept. 22, 2025
  • Modern glass and metal office building with a reflective blue-tinted facade, set against a clear blue sky. In the foreground, a large black and white sign reads “Abbott” with the company’s stylized logo and the number “645.” The area has neatly cut grass and a few small trees.
    Image attribution tooltip
    Alamy
    Image attribution tooltip

    FDA posts early alert about Abbott’s Tactiflex Ablation Catheter

    Catheter tips came off three damaged devices during surgery but none of the patients suffered serious injuries or died.

    By • Updated Sept. 22, 2025
  • A wall bearing the Johnson & Johnson logo is seen outside of an office building.
    Image attribution tooltip
    Courtesy of Johnson & Johnson
    Image attribution tooltip

    J&J launches IVL device in Europe; Medtronic looks at pacing for more patients

    J&J’s Shockwave Javelin intravascular lithotripsy catheter treats people with peripheral artery disease. Elsewhere, Medtronic began a pivotal trial to evaluate its pacemakers in a new patient group.

    By • Sept. 18, 2025
  • A commercial building displays a “Boston Scientific” sign on its exterior. The structure features a smooth white facade with reflective windows and minimal architectural detailing, set against a partly cloudy sky.
    Image attribution tooltip
    Alamy
    Image attribution tooltip

    Boston Scientific inks $88M Elutia deal to challenge Medtronic

    BTIG analysts estimate that Elutia’s Elupro and Medtronic’s TYRX are competing for a $600 million opportunity in the U.S. cardiac rhythm management sector.

    By • Updated Sept. 11, 2025
  • Pulse Biosciences' pulsed field ablation tool is displayed against a white background.
    Image attribution tooltip
    Permission granted by Pulse Biosciences
    Image attribution tooltip

    Pulse wins IDE approval; Galvanize pulls in $100M

    Pulse Biosciences will study PFA in cardiac surgery. Meanwhile, Galvanize Therapeutics also named a new CEO, and PFA pioneer Steven Mickelsen has launched another company.

    By • Sept. 9, 2025
  • FDA
    Image attribution tooltip
    Sarah Silbiger via Getty Images
    Image attribution tooltip

    Microbot receives 510(k) clearance for endovascular robot

    The company will now complete final commercial activities in preparation for targeting the 2.5 million peripheral vascular procedures performed in the U.S. each year.

    By • Sept. 9, 2025
  • A coil-shaped device is shown moving through a tube with branching structures around it.
    Image attribution tooltip
    Courtesy of Medtronic
    Image attribution tooltip

    Renal denervation gets strong backing from cardiologists ahead of Medicare coverage decision

    Doctors told the Centers for Medicare and Medicaid Services that more patients need access to the procedure, with one calling it the start of a new era in hypertension management.

    By • Sept. 4, 2025
  • Kardium's Globe mapping and ablation catheter for pulsed field ablation is shown.
    Image attribution tooltip
    Courtesy of Kardium
    Image attribution tooltip

    Kardium receives FDA OK for pulsed field ablation system

    The company raised $250 million in July to expand its manufacturing capabilities and establish multiple teams to support the launch.

    By • Sept. 4, 2025